The plasminogen activation system in tumor growth, invasion, and metastasis

被引:833
作者
Andreasen, PA [1 ]
Egelund, R [1 ]
Petersen, HH [1 ]
机构
[1] Aarhus Univ, Dept Biol Mol & Struct, Cellular Protein Sci Lab, DK-8000 Aarhus C, Denmark
关键词
serine proteinases; serpins; integrins; cell migration; anti-invasive therapy;
D O I
10.1007/s000180050497
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Generation of the serine proteinase plasmin from the extracellular zymogen plasminogen can be catalyzed by either of two other serine proteinases, the urokinase- and tissue-type plasminogen activators (uPA and tPA). The plasminogen activation system also includes the serpins PAI-1 and PAI-2, and the uPA receptor (uPAR). Many findings, gathered over several decades, strongly suggest an important and causal role for uPA-catalyzed plasmin generation in cancer cell invasion through the extracellular matrix. Recent evidence suggests that the uPA system is also involved in cancer cell-directed tissue remodeling. Moreover, the system also supports cell migration and invasion by plasmin-independent mechanisms, including multiple interactions between uPA, uPAR, PAI-1, extracellular matrix proteins, integrins, endocytosis receptors, and growth factors. These interactions seem to allow temporal and spatial reorganizations of the system during cell migration and a selective degradation of extracellular matrix proteins during invasion. The increased knowledge about the plasminogen activation system may allow utilization of its components as targets for anti-invasive therapy.
引用
收藏
页码:25 / 40
页数:16
相关论文
共 200 条
[1]   A MODEL OF THE REACTIVE FORM OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 [J].
AERTGEERTS, K ;
DEBONDT, HL ;
DERANTER, C ;
DECLERCK, PJ .
JOURNAL OF STRUCTURAL BIOLOGY, 1994, 113 (03) :239-245
[2]   DIVERSITY IN CATALYTIC PROPERTIES OF SINGLE CHAIN AND 2 CHAIN TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].
ANDREASEN, PA ;
PETERSEN, LC ;
DANO, K .
FIBRINOLYSIS, 1991, 5 (04) :207-215
[3]   RECEPTOR-MEDIATED ENDOCYTOSIS OF PLASMINOGEN ACTIVATORS AND ACTIVATOR/INHIBITOR COMPLEXES [J].
ANDREASEN, PA ;
SOTTRUPJENSEN, L ;
KJOLLER, L ;
NYKJAER, A ;
MOESTRUP, SK ;
PETERSEN, CM ;
GLIEMANN, J .
FEBS LETTERS, 1994, 338 (03) :239-245
[4]   PLASMINOGEN-ACTIVATOR INHIBITORS - HORMONALLY REGULATED SERPINS [J].
ANDREASEN, PA ;
GEORG, B ;
LUND, LR ;
RICCIO, A ;
STACEY, SN .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1990, 68 (01) :1-19
[5]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[6]  
2-Z
[7]   PRODUCTION OF 2ND MESSENGERS FOLLOWING CHEMOTACTIC AND MITOGENIC UROKINASE-RECEPTOR INTERACTION IN HUMAN FIBROBLASTS AND MOUSE FIBROBLASTS TRANSFECTED WITH HUMAN UROKINASE RECEPTOR [J].
ANICHINI, E ;
FIBBI, G ;
PUCCI, M ;
CALDINI, R ;
CHEVANNE, M ;
DELROSSO, M .
EXPERIMENTAL CELL RESEARCH, 1994, 213 (02) :438-448
[8]  
APPELLA E, 1987, J BIOL CHEM, V262, P4437
[9]   Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization [J].
Bajou, K ;
Noël, A ;
Gerard, RD ;
Masson, V ;
Brunner, N ;
Holst-Hansen, C ;
Skobe, M ;
Fusenig, NE ;
Carmeliet, P ;
Collen, D ;
Foidart, JM .
NATURE MEDICINE, 1998, 4 (08) :923-928
[10]   Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury [J].
Barazzone, C ;
Belin, D ;
Piguet, PF ;
Vassalli, JD ;
Sappino, AP .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (12) :2666-2673